Polymorphisms in Natural Killer Cell Receptor Protein 2D (NKG2D) as a Risk Factor for Cholangiocarcinoma
Christopher A. Wadsworth1, Peter H. Dixon2, Simon D. Taylor-Robinso1, Jin U. Kim1, Abigail A. Zabron1, Jason H. Wong1, Michael H. Chapman3, Siobhan C. McKay4, Duncan R. Spalding4, Harpreet S. Wasan5, Steve P. Pereira3, Howard C. Thomas1, John C. Whittaker6,7, Catherine Williamson2, Shahid A. Khan1
1Digestive Health Section, Department of Surgery and Cancer, St Mary’s Hospital Campus, Imperial College London, London, United Kingdom
2Department of Women and Children’s Health, School of Life Course Sciences, Guy’s Hospital Campus, King’s College London, London, United Kingdom
3Institute for Liver & Digestive Health, Royal Free Hospital Campus, University College London, London, United Kingdom
4Surgery Section, Department of Surgery and Cancer, Hammersmith Hospital Campus, Imperial College London, London, United Kingdom
5Oncology Section, Department of Surgery and Cancer, Hammersmith Hospital Campus, Imperial College London, London, United Kingdom
6Statistical Platforms and Technologies, Medicines Research Centre, GlaxoSmithKline, Stevenage, Hertfordshire, United Kingdom
7Statistical Genetics Unit, London School of Hygiene and Tropical Medicine, University of London, London, United Kingdom
Tài liệu tham khảo
Thông tin
Thông tin xuất bản
Journal of Clinical and Experimental Hepatology
Tập 9
171-175
Thông tin tác giả